|
|
|
|
|
The Niche
|
Stem Cell & Regenerative Med Newsletter
|
|
|
|
|
|
FDA warns more perinatal cell therapy firms: RenatiLabs & Cell Genuity
|
|
|
|
Starting last year the FDA has focused much of its cell therapy oversight resources on birth-related firms, including both clinics and suppliers. The latest warnings went to RenatiLabs & Cell Genuity. Warnings to unproven perinatal cell therapy firms Earlier this summer the agency warned Regenative Labs. There have been quite a few letters to others in this space as well. These warnings …
|
|
|
|
|
|
|
|
Small positive step for BlueRock Therapeutics Stem Cell Therapy for Parkinson's
|
|
|
|
Several groups including Viviane Tabar who is a founding scientist at BlueRock Therapeutics are moving forward on potential cell therapies for Parkinson's Disease. BlueRock just released some new data that's worth a look. Check out the new BlueRock poster. In today's post, I briefly discuss the new data. I also go into the larger context of what this means. BlueRock …
|
|
|
|
|
|
